Latest European Medicines Agency Stories
Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
First Positive Regulatory Agency Determination for a PCSK9 Inhibitor THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal
- Unanimous Recommendation to Grant European Marketing Authorization for Omidria Based on Benefit/Risk Profile - SEATTLE, May 22, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER),
AMSTERDAM, May 13, 2015 /PRNewswire/ -- Kiadis Pharma B.V.
BETHESDA, Md., May 11, 2015 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry,
US Orphan Designation Granted for MI-100 in June 2014, by Food and Drug Administration (FDA) DOYLESTOWN, Pa., May 4, 2015 /PRNewswire/ -- Makindus, Inc.
TAIPEI, May 4, 2015 /PRNewswire/ -- PharmaEngine, Inc. (TWO:4162) today announced that its licensing partner, Merrimack Pharmaceuticals, Inc.
GENEVA, May 4, 2015 /PRNewswire/ -- EspeRare today announced that the European Medicines Agency (EMA) has granted an Orphan Drug Designation (ODD) for rimeporide, its lead
REHOVOT, Israel and NEW YORK, May 1, 2015 /PRNewswire/ -- Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European
- HETLIOZ®, a circadian regulator, is the first and only product to receive a recommendation for approval for Non-24 in the European Union WASHINGTON, April 24, 2015 /PRNewswire/
- A woman chauffeur.
- A woman who operates an automobile.